ENTRY       D04475                      Drug
NAME        Insulin aspart (USP/INN);
            Insulin aspart (genetical recombination) (JP18);
            Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN);
            Insulin X 14;
            NovoRapid (TN);
            Novolog (TN)
PRODUCT     .INSULIN ASPART PROTAMINE AND INSULIN ASPART (A-S Medication Solutions)
            FIASP (Novo Nordisk)
            INSULIN ASPART (A-S Medication Solutions)
            INSULIN ASPART (A-S Medication Solutions)
            INSULIN ASPART (Novo Nordisk Pharma)
            INSULIN ASPART (REMEDYREPACK)
            INSULIN ASPART (REMEDYREPACK)
            INSULIN ASPART PROTAMINE AND INSULIN ASPART (Novo Nordisk Pharma)
            INSULIN ASPART PROTAMINE AND INSULIN ASPART (REMEDYREPACK)
            NOVOLOG (A-S Medication Solutions)
            NOVOLOG (A-S Medication Solutions)
            NOVOLOG MIX 70/30 (A-S Medication Solutions)
            NOVOLOG MIX 70/30 (A-S Medication Solutions)
            NOVOLOG MIX 70/30 (Novo Nordisk)
            WATER INJECTION (Novo Nordisk)
FORMULA     C256H381N65O79S6
EXACT_MASS  5821.6118
MOL_WEIGHT  5825.5424
SEQUENCE    (A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
            Gln Leu Glu Asn Tyr Cys Asn
            (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala
            Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Asp Lys Thr
            (Disulfide bridge: A6-A11, A7-B7, A20-B19)
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG01636  Insulin preparation
              DG01796  Insulin analog, fast-acting
            Metabolizing enzyme inducer
             DG01637  CYP1A2 inducer
REMARK      Therapeutic category: 2492
            ATC code: A10AB05 A10AD05
            Product: D04475<JP/US>
            Product (mixture): D10570<JP>
EFFICACY    Antidiabetic, Insulin receptor agonist
  DISEASE   Diabetes mellitus [DS:H00408 H00409]
COMMENT     insulin analog
TARGET      INSR (CD220) [HSA:3643] [KO:K04527]
  PATHWAY   hsa04910(3643)  Insulin signaling pathway
            hsa04930(3643)  Type II diabetes mellitus
INTERACTION CYP induction: CYP1A2 [HSA:1544]
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10A INSULINS AND ANALOGUES
                A10AB Insulins and analogues for injection, fast-acting
                 A10AB05 Insulin aspart
                  D04475  Insulin aspart (USP/INN) &lt;JP/US&gt;
                A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
                 A10AD05 Insulin aspart
                  D04475  Insulin aspart (USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Insulins
               Insulin, Rapid-acting
                Insulin Aspart
                 D04475  Insulin aspart (USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2492  Pancreatic hormones
                 D04475  Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP18); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG01636  Insulin preparation
               DG01796  Insulin analog, fast-acting
                D04475  Insulin aspart
             Metabolizing enzyme inducer
              DG01637  CYP1A2 inducer
               D04475  Insulin aspart
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01636  Insulin preparation
               D04475  Insulin aspart
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                INSR (CD220)
                 D04475  Insulin aspart (USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D04475  Insulin aspart (genetical recombination)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04475
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04475
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04475
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04475
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04475
DBLINKS     CAS: 116094-23-6
            PubChem: 17398122
///
